Ellen Puré

24.3k total citations · 5 hit papers
173 papers, 15.4k citations indexed

About

Ellen Puré is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ellen Puré has authored 173 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Immunology, 66 papers in Molecular Biology and 54 papers in Oncology. Recurrent topics in Ellen Puré's work include Cell Adhesion Molecules Research (35 papers), Proteoglycans and glycosaminoglycans research (31 papers) and T-cell and B-cell Immunology (28 papers). Ellen Puré is often cited by papers focused on Cell Adhesion Molecules Research (35 papers), Proteoglycans and glycosaminoglycans research (31 papers) and T-cell and B-cell Immunology (28 papers). Ellen Puré collaborates with scholars based in United States, Germany and Poland. Ellen Puré's co-authors include Daniel J. Rader, Carolyn A. Cuff, Steven Μ. Albelda, Richard K. Assoian, Robert L. Camp, Peter C. Isakson, James Monslow, Joanna Cichy, Albert Lo and E S Vitetta and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ellen Puré

172 papers receiving 15.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

2008 800 citations Qihong Huang, Kiranmai Gumireddy et al. profile →
Resolution of Lung Inflammation by CD44

2002 552 citations Priit Teder, R. William Vandivier et al. Science profile →
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Albert Lo, John Scholler et al. Cancer Immunology Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, John Scholler et al. Cancer Research profile →
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors

2023 129 citations Zebin Xiao, Leslie Todd et al. profile →

Peers

Countries citing papers authored by Ellen Puré

Since Specialization

Citations

This map shows the geographic impact of Ellen Puré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Puré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Puré more than expected).

Fields of papers citing papers by Ellen Puré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Puré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Puré. The network helps show where Ellen Puré may publish in the future.

Co-authorship network of co-authors of Ellen Puré

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Puré. A scholar is included among the top collaborators of Ellen Puré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Puré. Ellen Puré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-bet–expressing B cells promote atherosclerosis in apolipoprotein E–deficient mice 2025 ·The Journal of Immunology ·James J. Knox, (unknown), James Monslow, Debra Cromley, Daniel J. Rader, Ellen Puré, Michael P. Cancro	1
2	Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors 2023 ·Cancer Research ·Wenqun Zhong, Zebin Xiao, (unknown), (unknown), (unknown), Ziyan Yu, (unknown), Neil C. Sheppard, Serge Y. Fuchs, Xiaowei Xu, Meenhard Herlyn, Carl H. June, Ellen Puré, Wei Guo	39
3	Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74 2022 ·Clinical Cancer Research ·(unknown), Estela Noguera-Ortega, Zebin Xiao, Leslie Todd, John Scholler, Decheng Song, Maria Liousia, (unknown), Kexiang Xu, Kimberly J. Edwards, Michael D. Farwell, Carl H. June, Steven Μ. Albelda, Ellen Puré, Mark A. Sellmyer	34
4	Mechanisms of PDAC subtype heterogeneity and therapy response 2022 ·Trends in cancer ·Elisa Espinet, Lukas Klein, Ellen Puré, Shiv K. Singh	37
5	Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis 2020 ·Oncogene ·Christina Cho, (unknown), Amy R. Peck, Yunguang Sun, (unknown), Kanstantsin V. Katlinski, Jun Gui, Priya Govindaraju, Ellen Puré, Hallgeir Rui, Serge Y. Fuchs	19
6	Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner 2020 ·American Journal Of Pathology ·James Monslow, Leslie Todd, (unknown), Priya Govindaraju, Richard K. Assoian, Ellen Puré	15
7	Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype 2019 ·Cancer Research ·(unknown), Richard Barrett, Jaewon Kim, (unknown), Diana Avery, James Monslow, Hyunsoo Kim, Bang‐Jin Kim, Ellen Puré, Sandra Ryeom	6
8	FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors 2018 ·Cancer Immunology Research ·Viviana Cremasco, Jillian L. Astarita, Angelo L. Grauel, Shilpa Keerthivasan, Kenzie D. MacIsaac, Matthew C. Woodruff, Michael P. Wu, Lotte Spel, Stephen P. Santoro, Zohreh Amoozgar, Tyler Laszewski, Sara Cruz Migoni, Konstantin Knoblich, Anne Fletcher, Martin W. LaFleur, Kai W. Wucherpfennig, Ellen Puré, Glenn Dranoff, Michael C. Carroll, Shannon J. Turley	147
9	Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts 2017 ·Matrix Biology ·Diana Avery, Priya Govindaraju, Michele H. Jacob, Leslie Todd, James Monslow, Ellen Puré	151
10	Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization 2016 ·Cancer Immunology Research ·Kheng Newick, Shaun O’Brien, Jing Sun, Veena Kapoor, (unknown), Albert Lo, Ellen Puré, Edmund K. Moon, Steven Μ. Albelda	160
11	Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors 2015 ·Cancer Immunology Research ·Enxiu Wang, Liang-Chuan Wang, Ching‐Yi Tsai, Vijay Bhoj, (unknown), Edmund K. Moon, Kheng Newick, Jing Sun, Albert Lo, Timothy Baradet, Michael D. Feldman, David M. Barrett, Ellen Puré, Steven Albelda, Michael C. Milone	91
12	Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors 2014 ·Clinical Cancer Research ·Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi, Caleph B. Wilson, Raghuveer Ranganathan, Jing Sun, Veena Kapoor, John Scholler, Ellen Puré, Michael C. Milone, Carl H. June, James L. Riley, E. John Wherry, Steven Μ. Albelda	344
13	Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis 2013 ·Cancer Discovery ·T.S. Karin Eisinger‐Mathason, Minsi Zhang, Qiong Qiu, Nicolas Skuli, Michael S. Nakazawa, Tatiana A. Karakasheva, Vera Mucaj, Jessica E.S. Shay, Lars Stangenberg, Navid Sadri, Ellen Puré, Sam S. Yoon, David G. Kirsch, M. Celeste Simon	213
14	Notch1 Is Required for Kras-Induced Lung Adenocarcinoma and Controls Tumor Cell Survival via p53 2013 ·Cancer Research ·Silvia Licciulli, Jacqueline L. Avila, Linda Hanlon, Scott Troutman, Matteo Cesaroni, Smitha Kota, Brian Keith, M. Celeste Simon, Ellen Puré, Freddy Radtke, Anthony J. Capobianco, Joseph L. Kissil	93
15	P1-03-09: Significance of FAP, SMA and CD31 Expression in the Stroma of Breast Cancer. 2011 ·Cancer Research ·Julia Tchou, (unknown), Panpan Zhang, Yue Bi, Ramana V. Davuluri, (unknown), R. Sonali Majumdar, Carolyn Mies, Meenhard Herlyn, Ellen Puré	1
16	The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis 2008 ·Cancer Research ·Qihong Huang, Kiranmai Gumireddy, Mariëtte Schrier, Carlos le Sage, Remco Nagel, Suresh Nair, David Egan, An‐Ping Li, Guanghua Huang, Andres J. Klein–Szanto, (unknown), Dionyssios Katsaros, George Coukos, Lin Zhang, Ellen Puré, Reuven Agami	1
17	The Regulation and Activation of CD44 by Natural Killer (NK) Cells and Its Role in the Production of IFN-γ 2004 ·Journal of Interferon & Cytokine Research ·Sarah Sague, Cristina M. Tato, Ellen Puré, Christopher A. Hunter	34
18	Resolution of Lung Inflammation by CD44 breakdown → 2002 ·Science ·Priit Teder, R. William Vandivier, Dianhua Jiang, Jiurong Liang, Lauren Cohn, Ellen Puré, Peter M. Henson, Paul W. Noble	552
19	The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation 2001 ·Journal of Clinical Investigation ·Carolyn A. Cuff, Devashish Kothapalli, (unknown), Sam Chun, Yuanming Zhang, (unknown), Christine Y. Yeh, Anthony Secreto, Richard K. Assoian, Daniel J. Rader, Ellen Puré	257
20	A Role for CD44 in the Production of IFN-γ and Immunopathology During Infection with Toxoplasma gondii 2001 ·The Journal of Immunology ·(unknown), Ellen Puré, Christopher A. Hunter	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact